Press release content from Business Wire. The AP news staff was not involved in its creation.
HCA Healthcare Uses Its COVID-19 Registry by Forming Consortium With AHRQ and Research Institutions to Accelerate COVID-19 Research
January 26, 2021 GMT
NASHVILLE, Tenn. (BUSINESS WIRE) Jan 26, 2021
HCA Healthcare (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it has formed a consortium of prominent public and private research institutions to use HCA Healthcare’s vast data on COVID-19 hospital care to improve patient outcomes and public knowledge. The institutions – including the federal Agency for Health Research and Quality (AHRQ), Johns Hopkins University, Duke University, Meharry Medical College, Harvard Pilgrim Health Care Institute, and others – will gain access to the data in a research program directed by the HCA Healthcare Research Institute (HRI).
Share this article
Share this article
BOSTON, Jan. 26, 2021 /PRNewswire/ Ariadne Labs today announced three recipients of the Ariadne Labs Spark Grant innovation award. Now in its eighth year, the Spark Grant program was founded to spark new and early-stage ideas focused on addressing gaps in health care and improving delivery of care.
New this year, Ariadne Labs partnered with Harvard Medical School to award two Dean s Innovation Grants in Health Care Delivery to Harvard-affiliated faculty.
The 2020-2021 recipients were chosen following a competitive selection process from a diverse pool of candidates. The work of this year s awardees addresses gaps in care during the transition from prenatal to primary care, the expansion of home-based palliative care services for eligible patients, and the development of protocols for safe postpartum care following cesarean delivery for women in rural Africa.
Day-to-day Covid decisions are a complicated balancing act These two families show how nbcnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcnews.com Daily Mail and Mail on Sunday newspapers.
E-Mail
What The Viewpoint Says: The SARS-CoV-2 pandemic has brought renewed urgency to the question of what constitutes an aerosol-generating procedure. Four factors that explain transmission risk during aerosol-generating medical procedures are discussed in this article.
Authors: Michael Klompas, M.D., M.P.H., of Harvard Pilgrim Health Care Institute and Harvard Medical School in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https:/